GEN Exclusives

More »

GEN News Highlights

More »
Sep 13, 2007

SRI and Pentax to Advance Diagnostic Tool Development for Cancer

  • SRI International initiated a personalized medicine program to find cancer biomarkers to make diagnostic tools. This project is part of a multiyear collaboration with Pentax.

    Pentax will provide research funding and R&D milestone payments to SRI as well as royalties on sales of any resulting products.

    “Pentax and SRI are jointly addressing new opportunities in personalized medicine by developing diagnostic tools to assist in rapid and accurate selection of therapeutic options for treatment on an individual patient basis,” remarks Akira Yamamoto, research head at the Pentax Incubation Center and program director for the Pentax–SRI partnership.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?